BamSEC and AlphaSense Join Forces
Learn More

ResMed Inc.

NYSE: RMD    
Share price (11/21/24): $243.60    
Market cap (11/21/24): $35.8 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 3 pages ResMed Inc. Non-Employee Director Deferral Program
12/34/56
EX-10.5
from 10-K 33 pages Amended and Restated Resmed Inc. Deferred Compensation Plan, as Amended Through August 17, 2023 Effective Date July 1, 2010 1
12/34/56
EX-10.1
from 10-Q 17 pages Resmed Inc. Summary for Performance-Based Restricted Stock Unit (“Psu”) Award Agreement
12/34/56
EX-10.10
from 10-K 17 pages Resmed Inc. Summary for Restricted Stock Unit Award Agreement
12/34/56
EX-10.9
from 10-K 17 pages Resmed Inc. Summary for Performance-Based Restricted Stock Unit (“Psu”) Award Agreement
12/34/56
EX-10.7
from 10-K 14 pages Resmed Inc. Summary for Executive Stock Option Award Agreement
12/34/56
EX-10.10
from 10-K 18 pages Resmed Inc. Summary for Restricted Stock Unit Award Agreement (Designated Executives) Resmed Inc. Executive Restricted Stock Unit Award Agreement
12/34/56
EX-10.9
from 10-K 18 pages Resmed Inc. Summary for Performance-Based Restricted Stock Unit (“Psu”) Award Agreement
12/34/56
EX-10.8
from 10-K 10 pages Resmed Inc. Summary for Director Stock Option Award Agreement
12/34/56
EX-10.7
from 10-K 14 pages Resmed Inc. Summary for Executive Stock Option Award Agreement
12/34/56
EX-10.6
from 10-K 10 pages Resmed Inc. Summary for Restricted Stock Unit Award Agreement
12/34/56
EX-10.3
from 10-K 17 pages Executive Agreement Executive Officer
12/34/56
EX-10.3
from 8-K 127 pages Second Amendment to Syndicated Facility Agreement and First Amendment to Unconditional Guaranty
12/34/56
EX-10.2
from 8-K 9 pages Second Amended and Restated Unconditional Guaranty
12/34/56
EX-10.1
from 10-Q 22 pages Separation Agreement and General Release of All Claims
12/34/56
EX-10.11
from 10-K 19 pages  Resmed Inc. Summary for Restricted Stock Unit Award Agreement
12/34/56
EX-10.10
from 10-K 19 pages  Resmed Inc.  Summary for Performance-Based Restricted Stock Unit (“Psu”) Award Agreement
12/34/56
EX-10.1
from 8-K 124 pages Resmed Inc. $500,000,000 $250,000,000 3.24% Series a Senior Notes Due July 10, 2026 $250,000,000 3.45% Series B Senior Notes Due July 10, 2029 Note Purchase Agreement Dated as of July 10, 2019
12/34/56
EX-10.4
from 8-K 7 pages Unconditional Guaranty
12/34/56
EX-10.3
from 8-K 123 pages Syndicated Facility Agreement Dated as of April 17, 2018 Among Resmed Limited, as Borrower, Resmed Inc., as Parent, Mufg Union Bank, N.A., as Administrative Agent, Joint Lead Arranger and Joint Book Runner, Westpac Banking Corporation, as Syndication Agent, Joint Lead Arranger and Joint Book Runner, and the Other Lenders Party Hereto
12/34/56